The Weekly Roundup

February 24, 2017 | Pamela Youngberg Dickson

Spending on Specialty drugs has nearly doubled in the past five years and has contributed to massive overall medicine spending growth. This week, Drug Channels’ Adam Fein released his analysis of the 2016 Specialty pharmacy estimates naming the largest players in the $115 billion-dollar market. He deftly points out one of the challenges felt by many independents who want to grow their own Specialty practices: many PBMs limit the ability of an independent to compete by requiring patients to use the pharmacies that the PBMs own, concentrating most of the business year-after-year with two players—ExpressScripts and CVS Health. Still, there is opportunity in Specialty, and it may well be a good way to diversify. Our own Sterling Specialty president, Tim Gallagher, had the opportunity to talk about pharmacy’s foray into the Specialty field, and spoke to a group of interested pharmacists at the NCPA Specialty Conference in New Orleans last October. Here’s the transcript, if you missed it.

Here are few other stories that might be of interest:

[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at

Alzheimer's FDAOpioid AbusPBMSpecialtyVaccine

Pamela Youngberg Dickson

Before she came to Smart-Fill, Pamela developed marketing strategy and content for a range of technology start-ups and large-cap enterprises. Outside the office, she's into gardening, renaissance history, the Big Ten, and exploring the great outdoors.